We studied the influence of pre-transplant nutritional status on height velocity during the first post-transplant year. Thirty-seven children aged 1.4-12.4 years, 19 males and 18 females, underwent bone marrow transplantation (24 allogeneic, 13 autologous) with fractionated total body irradiation included in the preparative regimen of 25. The underlying diagnoses were leukemia (n = 16), malignant solid tumor (n = 11), and non-malignant hematologic or metabolic disease (n = 10). The serum concentrations of albumin, pre-albumin and transferrin were measured. Anthropometric measurements included weight, mid-arm circumference (MAC) and triceps skinfold thickness, expressed as percentages of the age-and sex-specific standards. The skeletal muscle protein reserve was estimated as muscle index (MI) by ultrasonographic imaging of the femoral quadriceps muscle. Height velocity was expressed as a standard deviation score (SDS) of the age-and sex-specific mean. The mean relative height velocity SDS was −1.6 (95% CI −2.2-−1.0). Height velocity correlated significantly with pre-transplant MI (r = 0.54, P = 0.004), concentration of serum transferrin (r = 0.33, P = 0.05) and MAC (r = 0.45, P = 0.04). Our data suggest that pretransplant nutritional status has an impact on growth in height during the post-transplant period.
Growth retardation is one of the most important long-term sequelae after bone marrow transplantation (BMT) in childhood. The causes of growth retardation are multiple, primarily including total body irradiation 1, 2 and corticosteroid treatment of graft-versus-host disease. 3 In addition, several kinds of endocrine deficiency 3, 4 may occur contributing to growth retardation.
Nutritional status greatly influences increase in height. Retarded growth has been observed in children with deficient nutrition in underdeveloped countries. 5, 6 In addition, poor nutritional status has been among the factors affecting growth in children with chronic diseases, including cerebral palsy and inflammatory bowel diseases. 7 nutritional status and suboptimal nutritional support are also a problem after BMT. 9, 10 Pre-and post-transplant malnutrition have been associated with an increased relapse rate and decreased survival. 9, 10 However, a correlation between nutritional parameters and growth after bone marrow transplantation has not been reported.
Our purpose was to evaluate the effect of pre-transplant nutritional status on increase in height during the first posttransplant year. Specifically, the usefulness of nutritional parameters was assessed in predicting height velocity after BMT.
Patients and methods

Patients
Our study group consisted of 59 consecutive BMT patients surviving beyond the first post-transplant year, the transplants having been carried out at the Hospital for Children and Adolescents, University of Helsinki, Finland, between January 1991 and March 1996. Twenty-two were excluded: seven patients had reached their final height, one patient underwent a double transplant program, and 14 were not sampled according to schedule. Of the 37 patients eligible for analysis, 13 had autologous and 24 had allogeneic grafts. The allogeneic donors were 15 HLA-matched siblings, two matched parental donors and four matched unrelated donors. In addition, two were cord blood transplants from HLA-identical siblings. Fractionated total body irradiation was used in the priming of 25 patients. Characteristics of the patients are presented in Table 1 . The study protocol was approved by the Institutional Review Board. Oral witnessed informed consent was obtained from the parents and age-appropriate patients.
Assessment of nutritional status
Laboratory measurements: Venous blood was drawn in the morning between 8 and 10 a.m. The samples were analyzed immediately. The concentration of serum albumin was measured by using the bromcresol purple reaction. The concentrations of prealbumin and transferrin were measured in immunoturbidometric assays (Orion Diagnostica, Espoo, Finland). The normal ranges for serum albumin, prealbumin and transferrin in our laboratory are 34-45 g/l, 170-420 mg/l and 1.75-3.13 g/l, respectively.
Anthropometric measurements: Weight in relation to ideal body weight for height (W%) was recorded using Finnish Weight % = weight in relation to ideal body weight for height. TBI = total body irradiation; BMI = body mass index.
growth charts. 11 Upper mid-arm circumference (MAC) and triceps skinfold (TRIC) thickness were measured in 20 patients, using standard procedures 12 and were expressed as percentages of age-and sex-specific means. Ultrasonography: Ultrasonography (Aloka Echo Camera, model SSD-210 DXII; Aloka, Tokyo, Japan) was employed to assess the thickness of the left femoral quadriceps muscle (QM, cm) at the mid-way point between the distal border of the patella and superior spine of the anterior iliac crest.
14 Ultrasonography was performed in 26 patients including those 20 from whom TRIC and MAC measurements were obtained. The skeletal muscle protein reserve was estimated by calculating the muscle index (MI), equal to QM 2 /S, where S = body surface area (m 2 ). The MI reference range of 7.5-10.5 cm 2 /m 2 was derived from the work of Koskelo and co-workers. 15 Throughout the study, both the anthropometric and ultrasound measurements were performed by one examiner (MT).
Evaluation of growth velocity
Height was measured by stadiometer to the nearest 0.1 cm before the transplant and 6 months and 1 year after transplantation. Height was expressed as ±SD of height for the age-and sex-specific mean. 11 Relative height velocity was expressed as a standard deviation score (SDS), and is based on data from a Swedish population. 16 In this model the effect of puberty on height velocity has been eliminated.
Total parenteral nutrition
Parenteral nutrition was instituted in every patient on the first post-transplant day. The duration of parenteral nutrition varied from patient to patient, the median being 24 (range 11-89) days. The target level of energy supply was calculated according to the age-based dietary recommendations for healthy children. 18 Parenteral nutrition was administered as 20% or 30% glucose (Glucos; LeirasKabi Infusions, Vantaa, Finland) together with a 20% lipid solution (Intralipid; Leiras-Kabi Infusion, Vantaa, Finland) and a 9% amino acid solution (Aminosteril; Medipolar, Oulu, Finland). The patients also received parenteral electrolytes, vitamins and trace elements. Nasogastric tubes were not used during the post-transplant neutropenic period.
Statistical analyses
Linear regression was used in analyzing the associations between growth velocity and nutritional parameters. Analysis of variance (ANOVA) was used in the analysis of repeated measurements. Multiple regression was used to find out the factors with the greatest impact on height velocity.
Results
Growth in height during the first post-transplant year
Relative height fell from −0.4 SD (95% CI −0.8-0.0) pretransplant to −0.5 SD (95% CI −0.9-−0.1) 1 year posttransplant (P = 0.21). Mean height velocity was 5.2 cm/year (95% CI 4.4-6.1). Mean relative height velocity was −1.6 SDS (95% CI −2.2-−1.0) of the mean height velocity for prepubertal children. Mean relative height velocity tended to be lower in patients primed with fractionated total body irradiation (TBI) (−1.7 SDS, 95% CI −2.3-−1.0) than in those not receiving TBI (−0.8 SDS, 95% CI −1.8-0.1; P = 0.06).
The five patients on corticosteroid treatment due to graftversus-host disease did not differ significantly from the others in height velocity.
Nutritional parameters before BMT
At the beginning of the BMT episode, weight was 100% (95% CIU 96-103) of the ideal weight for height. The mean triceps skinfold thickness and mid-arm circumference, expressed as percentages of the age-and sex-specific means, were 83% (95% CI 69-97) and 105% (95% CI 100-110), respectively. Body mass index was 16.3 kg/m 2 (95% CI 15.6-17.0). Mean muscle index, calculated from the ultrasonographic thickness of the femoral quadriceps muscle, was 6.6 cm 2 /m 2 (95% CI 5.6-6.6; reference range 7.5-10.5 cm 2 /m 2 ). Mean concentrations of serum albumin, prealbumin and transferrin prior to BMT were 37.5 g/l (95% CI 35.5-39.1), 187 mg/l (95% CI 168-206) and 1.8 g/l (95% CI 1.6-2.0), respectively.
Nutritional parameters, except for concentration of serum transferrin, were similar before BMT in patients primed with or without TBI. The pre-BMT concentration of serum transferrin was lower in patients who received TBI (1.7 g/l, 95% CI 1.5-1.9 vs 2.1 g/l, 95% CI 1.7-2.4; P = 0.04).
Factors influencing relative height velocity
We analyzed the effect of nutritional status represented by MI, total body irradiation, diagnosis (malignant vs metabolic or non-malignant hematological disease), and duration of post-transplant parenteral nutrition on the relative height velocity during the first post-transplant year in a multiple regression model. These parameters explained a significant part of the variance detected in relative height velocity (r = 0.65, P = 0.04). In the multiple regression model and in stepwise regression, MI was the strongest factor.
Nutritional parameters and post-BMT height velocity
The pre-transplant muscle index correlated significantly with height velocity during the first post-transplant year (r = 0.54, P = 0.004, Figure 1 ). Other indicators of nutritional status that showed some correlation with posttransplant height velocity were mid-arm circumference (r = 0.45, P = 0.04), triceps skinfold thickness (r = 0.36, P = 0.1), and body mass index (r = 0.30, P = 0.07) (Figure 1) .
Of the visceral proteins, pre-BMT concentration of serum transferrin correlated with height velocity during the first post-transplant year (r = 0.33, P = 0.05; Figure 1 ). Similar correlations were not observed regarding serum albumin or prealbumin. 
Discussion
In children, normal growth is the best evidence of optimal nutritional status. Height velocity could accordingly reflect nutritional status, although many other known factors are involved in BMT patients. We evaluated the influence of nutritional status on height velocity in 37 children during the first post-transplant year. Skeletal muscle protein reserves determined by ultrasonography, mid-arm circumference, and the concentration of serum transferrin all had a positive correlation with height velocity during this time.
In our patients, retardation of growth in height was to be expected during the first post-transplant year. The causes of growth retardation established to date have been hormonal, 1,3,4,17 osseous 18 and drug-related. 19 In accordance with others, 1,2,4 our data point to the harmful effect of irradiation on growth. However, in multiple regression analysis also including the effect of irradiation, the strongest factor affecting growth after BMT was the poor pretransplant protein reserve of skeletal muscle. The correlation of relative height velocity with mid-arm circumference, triceps skinfold thickness, BMI, as well as the concentration of serum transferrin, put more emphasis on the influence of nutritional parameters on growth during the early post-transplant period. Therefore, provision of adequate nutritional support both pre-and post-transplant is essential in order to achieve as optimal growth as possible under the circumstances. However, in the long run the roles of irradiation and prolonged steroid medication might become more evident in decreasing height velocity. 1, 2, 4 In comparison with changes in weight-linked nutritional parameters and concentrations of visceral proteins, skeletal muscle protein reserves were severely reduced. At tissue level this means a more severe lack of substrate than could be predicted based on the anthropometric measurements. As indicators of protein energy reserves anthropometric measurements should be treated with caution. They are based on assumptions made about muscle composition during malnutrition and may be inaccurate and overestimate muscle protein reserves. [20] [21] [22] Direct measurement of skeletal muscle by computerized tomography imaging has been more closely related to urinary creatinine excretion than anthropometric measurements. 23 Ultrasonographic measures are highly correlated with computerized tomography imaging of muscles 14 and should thus be equally valid for estimating skeletal muscle protein reserves.
In our patients, poor pre-transplant protein reserves, as indicated by a low muscle index and a low serum transferrin concentration, were associated with reduced height velocity after BMT (Figure 1) . No association has previously been found between a nutritional parameter and post-transplantational height velocity. 2, 24 The effect of total body irradiation cannot be the explanation, because patients receiving or not receiving TBI had similar pre-transplant muscle indices. Total parenteral nutrition did not decrease the fundamental importance of pre-transplant proteinenergy status.
The correlation between poor muscle protein reserves and retarded gain in height suggests that factors such as insulin-like growth factor-1 (IGF-1) might be involved. Deficiency of IGF-1 would result both in impaired utiliz-ation of nitrogen, in muscle protein synthesis and in impaired growth. 25, 26 Of interest is the observation that parenteral nutrition given was not sufficient enough to overcome the fundamental effect of pre-transplant nutritional status on post-transplant height velocity. The average duration of parenteral nutrition was 24 days. Longer duration of nutritional support might have been of benefit. For example, enteral nutritional support is possible in most patients even after discharge home. Furthermore, nutritional support should be introduced early enough before BMT in patients with reduced skeletal muscle protein reserve.
In conclusion, assessment of nutritional status should be an essential part of the pre-BMT evaluation. Poor protein energy status before BMT should be considered as a risk factor as regards early growth retardation after transplantation. Nutritional support before BMT and also after discharge home is important.
